The U.S. Senate has passed the Cannabidiol and Marijuana Research Expansion Act. The act would let the U.S. Attorney General increase the number of federally licensed entities authorized to cultivate cannabis for FDA-approved research purposes. Currently, only the University of Mississippi is authorized to grow cannabis for use in FDA clinical studies. The U.S. House of Representatives Dec. 9 passed a similar bill, the Medical Marijuana Research Act, which proposes to let authorized scientists access cannabis from state-approved cannabis programs for clinical trials.
Posted By: HempToday® December 28, 2020
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.